Chlorite-Detoxifying Microbial Communities in Chlorine Dioxide-Treated Cooling Systems: What Chlorite Dismutase Does and Does Not Mean

    Chlorite dismutase removes the by-product, not the disinfectant. Why enrichment of chlorite-detoxifying bacteria in a chlorine dioxide-treated cooling circuit is not evidence of chlorine dioxide resistance, and what to check instead.

    Evidence-led guidance
    Expert Reviewed

    Some bacteria carry chlorite dismutase, an enzyme that converts chlorite, the main reduction product of chlorine dioxide, into chloride and oxygen. In a continuously dosed cooling circuit that trait can be selected for. It is easy to read that as 'resistance to chlorine dioxide'. It is not the same thing, and confusing the two leads to the wrong operational response. This PT11 guide separates chlorite detoxification from chlorine dioxide tolerance and explains what each means for data-centre and industrial cooling water.

    Two different chemicals, two different microbial responses

    Chlorine dioxide (ClO₂) is a radical oxidant. It kills by accepting an electron from cellular targets, notably thiol groups and other electron-rich sites in proteins, and in doing so it becomes chlorite (ClO₂⁻). Chlorite is a much weaker oxidant that persists in the water. In a chlorine dioxide-treated cooling circuit, therefore, the water carries two distinct chlorine species: the transient disinfectant and its accumulating, less reactive by-product. Bacteria can respond to each separately.

    Tolerance of chlorine dioxide itself is a matter of surviving the oxidant: thicker matrix that consumes it before it reaches cells, reduced permeability, antioxidant systems, or simply living in the layer of a biofilm that the residual never reaches. That is the ordinary biofilm-tolerance story described elsewhere in this centre. Detoxification of chlorite is something else. A specific haem enzyme, chlorite dismutase (Cld), catalyses ClO₂⁻ → Cl⁻ + O₂. An organism that carries it can remove chlorite from its immediate surroundings. It gains nothing against chlorine dioxide by doing so, because chlorine dioxide has already acted by the time chlorite exists.

    How widespread chlorite dismutase is

    Chlorite dismutase was first characterised in bacteria that respire perchlorate and chlorate, where it disposes of the chlorite those pathways generate. It is now known to be far more widely distributed. A 2022 comparative-genomics analysis in The ISME Journal (Barnum and Coates, PMC9751292) found Cld genes in roughly five per cent of bacterial and archaeal genera, subject to extensive horizontal gene transfer, and often present in obligate aerobes that have no perchlorate-respiring machinery at all. The authors' interpretation is that chlorite, like hypochlorous acid, is encountered as an oxidative stress in ordinary habitats, and Cld is a defence against it. In their metagenome survey Cld was most enriched in oligotrophic rock, sediment and ice, followed by oxic wastewater and surface freshwater.

    That distribution matters for cooling water because a recirculating tower is inoculated continuously by make-up water and by air. A Cld-carrying organism arriving in a circuit dosed with chlorine dioxide would experience a steady chlorite background and, if it can survive the chlorine dioxide itself, might gain a modest advantage. It is therefore plausible that continuous dosing enriches such organisms over time. That is a hypothesis, not an established finding: no study cited here has demonstrated it in a chlorine dioxide-treated cooling system, and a taxonomic survey alone cannot show that the enriched organisms carry or express Cld, or that chlorite was the selective pressure rather than temperature, nutrients or the oxidant itself. Confirming it would need gene- or function-level evidence (Cld detection or measured chlorite removal) alongside the water chemistry.

    What the cooling-water and chlorine dioxide community studies actually show

    Direct field evidence on chlorine dioxide-treated cooling systems is thin, and this guide does not cite a study that it could not verify. What the peer-reviewed literature does establish is the general pattern. A 2020 Water Research study of an industrial cooling tower (Pinel et al.) that combined flow cytometry, ATP and 16S rRNA sequencing over five months under continuous chlorination at about 0.35 to 0.41 mg Cl₂/L found that the tower community was seeded by the feed water and then shaped by differential decay: most members declined, but the order Obscuribacterales grew in the tower in the presence of the residual, with a recurrent net growth of about 260 per cent. A disinfectant residual, in other words, does not sterilise a tower; it filters the incoming community and lets the tolerant fraction expand.

    For chlorine dioxide specifically, a 2024 study in the Journal of Hazardous Materials (Tang et al.; PubMed 39018597) characterised the 'disinfection-residual bacteria' that remain after chlorine dioxide treatment, reporting a shifted community structure, measurable regrowth potential and altered secretion characteristics compared with the untreated community. The organisms that remain after chlorine dioxide are not a random subset; they are the tolerant subset, and they can regrow when the residual lapses. Neither study identified chlorite dismutase as the mechanism, and neither concerned data-centre cooling in particular. They are cited here for the pattern, not for a mechanism they did not test.

    Why the distinction changes the operational response

    If a sequencing survey of a chlorine dioxide-treated circuit reports enrichment of taxa known to carry Cld, the tempting conclusion is that the biocide has stopped working and the dose should rise. That does not follow. Even if chlorite detoxification is confirmed, it means the by-product is being removed biologically, which, if anything, lowers measured chlorite in the bulk water. It says nothing about whether chlorine dioxide is reaching the biofilm at an effective concentration. The questions to ask are the ordinary ones: what is the chlorine dioxide residual at the far points of the circuit under load, is the make-up demand consuming it before it reaches the fill and heat exchangers, are deposits and scale shielding attached growth, and what do sessile counts or coupon inspections show?

    Conversely, a genuine loss of control, rising planktonic counts and dipslide or coupon biofilm despite a maintained residual, is a chlorine dioxide-tolerance question, not a chlorite question. The response is to check contact, penetration and deposit control, review residual placement and monitoring points, and consider mechanical cleaning or a shock treatment within the product's label and applicable authorisation conditions or transitional evidence, and the site's written scheme. HSE's HSG274 Part 1 framework already provides the structure for that review.

    Data-centre cooling specifics

    Data-centre cooling towers and adiabatic systems run at high duty and often with high cycles of concentration to save water, so the make-up water's mineral and organic load is concentrated in the circuit. That raises chlorine dioxide demand and can raise chlorite accumulation, because more of the dose is consumed by non-microbial demand. It also means that blowdown, not biology, is the main route by which chlorite leaves the system. Operators reading a low chlorite result should establish whether it reflects low dosing, high blowdown, downstream reaction with iron or other reductants, or biological detoxification before drawing conclusions, and should not treat any of those as a proxy for microbial control.

    Where a site uses a PT11 chlorine dioxide product that is authorised or supported by applicable transitional evidence for the intended use, its dosing, residual targets and monitoring belong to the product label and the site's written scheme. Nothing in the community studies discussed here sets a dose or a residual for any product, and no ChloroKlean product was tested in them.

    Evidence and uncertainty

    Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.

    For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.

    Choosing the next question

    A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.

    Where a product is considered, confirm the intended use, lawful GB BPR route and label directions independently of this educational guide.

    A proportionate biofilm-management approach

    Use this sequence to frame investigation and control; it is not a dosing protocol.

    1

    Define the system and risk

    Map wetted surfaces, operating conditions, users and relevant legal or sector guidance.

    2

    Gather evidence

    Review inspection, operational, residual and microbiological records rather than relying on one indicator.

    3

    Address contributing conditions

    Consider cleaning, hydraulics, nutrients, stagnation and equipment condition alongside any lawfully supplied biocide programme.

    4

    Verify and review

    Document the intervention and review results through the site’s written scheme or hygiene plan.

    Expert Insights

    "Biofilm control is a system-management question: chemistry, surfaces, flow, cleaning and verification all matter."

    ChloroKlean Technical Team

    Technical review team

    About the Reviewer

    Gavin Owen

    Managing Director, ChloroKlean

    Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.

    BPR Compliance
    Water Treatment
    Legionella Control
    Industrial Disinfection

    Frequently Asked Questions

    Common questions about this topic, answered by our technical team.

    No. Chlorite dismutase converts chlorite, the by-product left after chlorine dioxide has already reacted, into chloride and oxygen. It confers no protection against chlorine dioxide itself. Tolerance of chlorine dioxide comes from other mechanisms, chiefly the biofilm matrix and location within it.

    Not on that basis. Enrichment of taxa associated with chlorite detoxification is, at most, a hypothesis about the chlorite background that any chlorine dioxide-dosed circuit will have; a taxonomic survey does not confirm the mechanism or the cause. Decisions about dose belong to measured residual at representative points, planktonic and sessile monitoring, the product label and applicable authorisation conditions or transitional evidence, and the site's written scheme.

    In itself, no; it removes a regulated by-product. The caution is interpretive: a low chlorite result can reflect biological removal, blowdown, reaction with reductants or simply low dosing, so it should not be used as evidence of microbial control or of dosing adequacy.

    This guide could not verify a peer-reviewed study of chlorite-detoxifying communities in chlorine dioxide-treated data-centre cooling systems, and does not cite one. The mechanism (chlorite dismutase) and the pattern (residuals selecting tolerant communities in towers and after chlorine dioxide treatment) are each established separately in the studies cited.

    No. Dosing, residual targets and monitoring for a PT11 product that is authorised or supported by applicable transitional evidence are set by its label and the site's written scheme under HSG274. None of the studies discussed tested a ChloroKlean product.

    Start with the system’s risk assessment, operational records and applicable sector guidance. Use the referenced sources to frame questions, not to replace competent site assessment.

    Scope and safe-use note

    • This is general educational information, not a dosing instruction or a product label.
    • Use only a biocidal product that is authorised for its intended use or lawfully supplied under applicable GB BPR transitional arrangements, and follow its label, Safety Data Sheet and site risk assessment.
    • Investigate system design, cleaning, monitoring and microbiological findings with a competent person where there is a health risk.

    Published evidence about a disinfectant or another product does not establish efficacy, authorisation or an appropriate use pattern for any ChloroKlean product.

    Related Resources

    Continue exploring our knowledge base and product information.

    Sources & References

    This article references guidance from the following authoritative sources:

    External links open in a new window. ChloroKlean is not responsible for the content of external websites.

    Need Help Choosing the Right Product?

    Our technical team can advise on product selection, dosing, and compliance for your specific application.